We are live on
!
Find out more
Kiniksa Pharmaceuticals
KNSA
KNSA
104 hedge funds and large institutions have $437M invested in Kiniksa Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 55 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
267% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 15
64% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 14
17% more call options, than puts
Call options by funds: $1.49M | Put options by funds: $1.27M
8% more funds holding
Funds holding: 96 → 104 (+8)
7.21% more ownership
Funds ownership: 84.21% → 91.42% (+7.2%)
19% less capital invested
Capital invested by funds: $539M → $437M (-$102M)
Holders
104
Holders Change
+8
Holders Change %
+8.33%
% of All Funds
2.1%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
23
Increased
55
Reduced
15
Closed
14
Calls
$1.49M
Puts
$1.27M
Net Calls
+$214K
Net Calls Change
+$20K
Top Buyers
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$21.8M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$21M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.3M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$12.1M |
| 5 |
BlackRock
New York
|
+$11.9M |
Top Sellers
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$10M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$8.8M |
| 3 |
EP
Eversept Partners
New York
|
-$2.08M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.28M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$1.27M |
